Ironwood Pharmaceuticals Inc (NAS:IRWD)
$ 4.45 -0.14 (-3.05%) Market Cap: 712.13 Mil Enterprise Value: 1.26 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q3 2021 Ironwood Pharmaceuticals Inc Earnings Call Transcript

Nov 04, 2021 / 12:30PM GMT
Release Date Price: $12.58 (-2.10%)
Operator

Good morning My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals Third Quarter 2021 Investor Update Call. (Operator Instructions)

Thank you. Matt Roache, Director of Investor Relations, you may begin your conference.

Matt Roache
Ironwood Pharmaceuticals, Inc. - Director of IR

Good morning, and thanks for joining us for our third quarter 2021 investor update. Our press release crossed the wire this morning and can be found on our website. Today's call and accompanying slides include forward-looking statements. Such statements involve risks and uncertainties that may cause actual results to differ materially. A discussion of these statements and risk factors is available on the current safe harbor statement slide as well as under the heading Risk Factors in our quarterly report on Form 10-Q for the quarter ended June 30, 2021, and in our future SEC filings. All forward-looking statements speak as of the date of this presentation, and we undertake no obligation to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot